Page last updated: 2024-11-03

rabeprazole and Stevens-Johnson Syndrome

rabeprazole has been researched along with Stevens-Johnson Syndrome in 2 studies

Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kikuchi, S1
Nobeyama, Y1
Saeki, H1
Asahina, A1
Chularojanamontri, L1
Jiamton, S1
Manapajon, A1
Suvanasuthi, S1
Kulthanan, K1
Dhana, N1
Jongjarearnprasert, K1

Other Studies

2 other studies available for rabeprazole and Stevens-Johnson Syndrome

ArticleYear
Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication.
    The Journal of dermatology, 2020, Volume: 47, Issue:3

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithrom

2020
Cutaneous reactions to proton pump inhibitors: a case-control study.
    Journal of drugs in dermatology : JDD, 2012, Volume: 11, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Cas

2012